Bliss GVS Pharma Limited

NSE BLISSGVS.NS

Bliss GVS Pharma Limited Market Capitalization on January 14, 2025: USD 195.14 M

Bliss GVS Pharma Limited Market Capitalization is USD 195.14 M on January 14, 2025, a 20.27% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Bliss GVS Pharma Limited 52-week high Market Capitalization is USD 229.61 M on January 07, 2025, which is 17.66% above the current Market Capitalization.
  • Bliss GVS Pharma Limited 52-week low Market Capitalization is USD 121.77 M on June 04, 2024, which is -37.60% below the current Market Capitalization.
  • Bliss GVS Pharma Limited average Market Capitalization for the last 52 weeks is USD 156.02 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NSE: BLISSGVS.NS

Bliss GVS Pharma Limited

CEO Mr. Gagan Harsh Sharma
IPO Date July 26, 2010
Location India
Headquarters 102, Hyde Park
Employees 831
Sector Health Care
Industries
Description

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Similar companies

SHILPAMED.NS

Shilpa Medicare Limited

USD 9.00

6.34%

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 26.96

3.45%

DCAL.NS

Dishman Carbogen Amcis Limited

USD 3.00

2.25%

INDOCO.NS

Indoco Remedies Limited

USD 3.76

0.04%

BALMLAWRIE.NS

Balmer Lawrie & Co. Ltd.

USD 2.30

1.13%

StockViz Staff

January 15, 2025

Any question? Send us an email